AMERI Holdings, Inc. (88) | Business Finance (59)
Browse by Subcategory
Recent Contracts
-
Form of Warrant Amendment
(Filed With SEC on July 26, 2022)
-
Form of Registration Rights Agreement
(Filed With SEC on July 26, 2022)
-
Form of PIPE Securities Purchase Agreement
(Filed With SEC on July 26, 2022)
-
Certificate of the Designations, Preferences and Rights of Series A Convertible Preferred Stock
(Filed With SEC on May 11, 2022)
-
Underwriting Agreement, dated February 11, 2022, by and between Enveric Biosciences, Inc. and A.G.P./Alliance Global Partners
(Filed With SEC on February 15, 2022)
-
Amendment No. 2 to Assignment and Assumption Agreement (U.S. GVHD Sublicense and Skincare), dated October 2, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and TO...
(Filed With SEC on April 1, 2021)
-
Amendment No. 3 to Secured Promissory Note, dated August 12, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Form of Debenture
(Filed With SEC on September 11, 2020)
-
Form of Exchange Agreement
(Filed With SEC on September 11, 2020)
-
Form of Maturity Extension and Forbearance Agreement, dated May 6, 2020
(Filed With SEC on May 6, 2020)
-
Share Purchase Agreement, dated January 10, 2020, by and between AMERI Holdings, Inc. and Ameri100, Inc
(Filed With SEC on January 13, 2020)
-
Corporate Guaranty, dated January 23, 2019, by the Company in favor of North Mill Capital LLC
(Filed With SEC on January 25, 2019)
-
Revolving Credit Master Promissory Note, dated January 23, 2019
(Filed With SEC on January 25, 2019)
-
Security Agreement, dated January 23, 2019, by and between the Company and North Mill Capital LLC
(Filed With SEC on January 25, 2019)
-
Loan and Security Agreement, dated January 23, 2019, by and between (i) Ameri100 Arizona LLC, (ii) Ameri100 Georgia, Inc., (iii) Ameri100 California, Inc. and (iv) Ameri and...
(Filed With SEC on January 25, 2019)
-
Form of Registered Direct Securities Purchase Agreement
(Filed With SEC on July 26, 2022)
-
Form of Wainwright Warrant
(Filed With SEC on July 26, 2022)
-
Form of PIPE Pre-Funded Warrant
(Filed With SEC on July 26, 2022)
-
Form of RD Pre-Funded Warrant
(Filed With SEC on July 26, 2022)
-
Form of Warrant
(Filed With SEC on May 11, 2022)
-
Form of Registration Rights Agreement
(Filed With SEC on May 11, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on May 11, 2022)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on February 15, 2022)
-
Form of MagicMed Warrant Certificate
(Filed With SEC on September 17, 2021)
-
MagicMed Stock Option Plan, as amended September 10, 2021
(Filed With SEC on September 17, 2021)
-
Form of Series B Warrant
(Filed With SEC on April 1, 2021)
-
Amendment No. 1 to Assignment and Assumption Agreement (U.S. GVHD Sublicense and Skincare), dated August 12, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and TO...
(Filed With SEC on April 1, 2021)
-
Assignment and Assumption Agreement (U.S. GVHD Sublicense and Skincare), dated January 10, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and TO Pharmaceuticals USA LLC
(Filed With SEC on April 1, 2021)
-
Amendment No. 2 to Assignment and Assumption Agreement (Non-U.S. GVHD Sublicense and Skincare), dated October 2, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and Tikun...
(Filed With SEC on April 1, 2021)
-
Amendment No. 1 to Assignment and Assumption Agreement (Non-U.S. GVHD Sublicense), dated August 12, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and Tikun Olam IP Ltd
(Filed With SEC on April 1, 2021)
-
Assignment and Assumption Agreement (Non-U.S. GVHD Sublicense), dated January 10, 2020, by and among Tikkun Pharma, Inc., Jay Pharma Inc. and Tikun Olam IP Ltd
(Filed With SEC on April 1, 2021)
-
Amendment No. 3 to Securities Purchase Agreement, dated August 12, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Amendment No. 2 to Securities Purchase Agreement, dated July 2, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Securities Purchase Agreement, dated January 10, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Amendment No. 2 to Secured Promissory Note, dated June 23, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Amendment No. 1 to Secured Promissory Note, dated May 6, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Secured Promissory Note, dated January 10, 2020, by and between Alpha Capital Anstalt and Jay Pharma Inc
(Filed With SEC on April 1, 2021)
-
Form of Registration Rights Agreement
(Filed With SEC on February 11, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on February 11, 2021)
-
Form of Warrant
(Filed With SEC on February 11, 2021)
-
Form of Registration Rights Agreement
(Filed With SEC on January 12, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on January 12, 2021)
-
Form of Warrant
(Filed With SEC on January 12, 2021)
-
Form of Pre-funded Warrant
(Filed With SEC on January 12, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on August 3, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on August 3, 2020)
-
Form of Warrant
(Filed With SEC on August 3, 2020)
-
Form of Debenture
(Filed With SEC on June 4, 2020)
-
Form of Exchange Agreement
(Filed With SEC on June 4, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 4, 2020)
-
Promissory Note from Sterling National Bank, due May 6, 2022
(Filed With SEC on May 15, 2020)
-
Form of Pre-Funded Warrant, dated May 6, 2020
(Filed With SEC on May 6, 2020)
-
Form of Series B Warrant, dated May 6, 2020
(Filed With SEC on May 6, 2020)
-
Form of Registration Rights Agreement, dated May 6, 2020
(Filed With SEC on May 6, 2020)
-
Secured Promissory Note
(Filed With SEC on March 4, 2020)
-
Note Purchase and Security Agreement
(Filed With SEC on March 4, 2020)
-
Form of Convertible Debenture
(Filed With SEC on November 25, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on November 25, 2019)
-
Form of Exchange Agreement
(Filed With SEC on September 20, 2019)